2004-05-04
Lack of efficacy of Doxil® in TNF-α-based isolated limb perfusion in sarcoma-bearing rats
Publication
Publication
British Journal of Cancer , Volume 90 - Issue 9 p. 1830- 1832
Here we show that Doxil® has minimal antitumour activity in the isolated limb perfusion (ILP) setting and its activity was not enhanced by the addition of tumour necrosis factor (TNF). Doxil® accumulation in tumour tissue was low and also not augmented by TNF. In contrast, activity of free conventional doxorubicin was enhanced by TNF. We conclude that application of Doxil® in a TNF-based ILP is not a useful alternative to free conventional doxorubicin or melphalan.
| Additional Metadata | |
|---|---|
| , , , , | |
| doi.org/10.1038/sj.bjc.6601688, hdl.handle.net/1765/67090 | |
| British Journal of Cancer | |
| Organisation | Department of Surgery |
|
ten Hagen, T., Hoving, S., Aan de Wiel-Ambagtsheer, G., van Tiel, S., & Eggermont, A. (2004). Lack of efficacy of Doxil® in TNF-α-based isolated limb perfusion in sarcoma-bearing rats. British Journal of Cancer, 90(9), 1830–1832. doi:10.1038/sj.bjc.6601688 |
|